Skip to main content
. 2018 Aug 31;9(68):33043–33049. doi: 10.18632/oncotarget.25984

Figure 4. General schema of the evolution of the patient.

Figure 4

Nivolumab infusions (green arrows), the duration of the irAEs and cortisone treatment is reported. The CT scan evaluations are indicated with the radiological response: partial response (PR), new lesion (NL), progression disease (PD), and hepatic flare progression disease (HPD).